Abstract
ABSTRACT Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
